Nanobiotix S.A. (NBTX)

Nanobiotix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	247	256	128	282	537	-
Market Cap Growth	-9.08%	100.38%	-54.63%	-47.46%	-	-
Enterprise Value	220	229	141	239	451	11
PE Ratio	-	-5.81	-2.11	-5.28	-13.11	-
PS Ratio	6.14	6.38	25.19	93.78	175.25	-
PB Ratio	-125.25	-125.25	-4.45	9.27	6.25	-
P/FCF Ratio	-18.02	-18.02	-3.23	-8.25	-15.92	-
P/OCF Ratio	-18.50	-18.50	-3.24	-8.31	-15.99	-
EV/Sales Ratio	5.48	5.69	27.66	79.46	147.31	3.71
EV/EBITDA Ratio	-8.86	-8.86	-3.17	-4.71	-10.73	-0.21
EV/EBIT Ratio	-8.32	-8.32	-3.06	-4.55	-10.21	-0.21
EV/FCF Ratio	-16.09	-16.09	-3.55	-6.99	-13.39	-0.22
Debt / Equity Ratio	-27.44	-27.44	-1.97	1.72	0.70	-23.34
Debt / EBITDA Ratio	-2.17	-2.17	-1.28	-1.03	-1.42	-1.01
Debt / FCF Ratio	-3.95	-3.95	-1.43	-1.53	-1.77	-1.04
Quick Ratio	1.53	1.53	1.09	2.28	6.26	2.45
Current Ratio	1.75	1.75	1.38	2.53	6.58	3.22
Asset Turnover	0.47	0.47	0.06	0.02	0.03	0.05
Interest Coverage	-1.67	-1.67	-3.11	-59.25	-	-9.24
Return on Equity (ROE)	274.90%	274.90%	44738.00%	-96.70%	-98.00%	-825.50%
Return on Assets (ROA)	-51.70%	-51.70%	-70.60%	-39.90%	-35.30%	-99.40%
Return on Capital (ROIC)	-54.96%	-54.96%	-178.78%	-72.21%	-30.50%	-109.76%
Earnings Yield	-17.87%	-17.20%	-47.41%	-18.93%	-7.63%	-
FCF Yield	-5.58%	-5.55%	-30.92%	-12.13%	-6.28%	-
Buyback Yield / Dilution	-1.16%	-1.02%	-0.14%	-7.03%	-	-
Total Shareholder Return	-1.16%	-1.02%	-0.14%	-7.03%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).